Jushi Holdings (JUSHF) Income from Continuing Operations (2021 - 2026)

Jushi Holdings (JUSHF) reported Income from Continuing Operations of 19847000.0 for Q1 2026, down 16.64% year-over-year from 23809962.98 in Q1 2025, and down 27.58% quarter-over-quarter from 15556000.0 in Q4 2025.

Jushi Holdings (JUSHF) Income from Continuing Operations (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Income from Continuing Operations data on file, last reported at 19847000.0 in Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 19847000.0, down 16.64% year-over-year; the trailing twelve-month figure through Mar 2026 was 71423000.0 (down 50.56% YoY), and the FY2025 annual result was 68591000.0, down 40.62% from the prior year.
  • Income from Continuing Operations slipped to 19847000.0 in Q1 2026 per JUSHF's latest filing, from 15556000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 12066000.0 in Q2 2022 and troughed at 139937000.0 in Q4 2022.
  • A 5-year average of 23802411.76 and a median of 17015000.0 in 2025 frame the typical range for Income from Continuing Operations.
  • On a YoY basis, Income from Continuing Operations climbed as much as 357.74% in 2022 and fell as far as 2353.05% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 139937000.0 in 2022, then surged by 87.13% to 18004000.0 in 2023, then surged by 30.75% to 12468000.0 in 2024, then dropped by 24.77% to 15556000.0 in 2025, then slipped by 27.58% to 19847000.0 in 2026.
  • Business Quant data shows JUSHF's Income from Continuing Operations at 19847000.0 in Q1 2026, 15556000.0 in Q4 2025, and 23689000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 370.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -66.53 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -92.12 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 118.42 Mn
10 Jushi Holdings - - 29.88 Mn -19.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.85 Mn
Dec 31, 2025 -15.56 Mn
Sep 30, 2025 -23.69 Mn
Jun 30, 2025 -12.33 Mn
Mar 31, 2025 -17.02 Mn
Dec 31, 2024 -12.47 Mn
Sep 30, 2024 -16.02 Mn
Jun 30, 2024 -1.94 Mn
Mar 31, 2024 -18.36 Mn
Dec 31, 2023 -18.00 Mn
Sep 30, 2023 -20.62 Mn
Jun 30, 2023 -14.04 Mn
Mar 31, 2023 -12.44 Mn
Dec 31, 2022 -139.94 Mn
Sep 30, 2022 -54.70 Mn
Jun 30, 2022 12.07 Mn
Mar 31, 2022 -19.76 Mn
Dec 31, 2021 6.21 Mn
Sep 30, 2021 39.68 Mn
Jun 30, 2021 2.64 Mn